Table 2.
Annualized outcomes at 12 months for Veterans Affairs patients with gout
| Outcomesa | Controlled (n = 193,596) |
Uncontrolled (n = 138,068) |
p value |
|---|---|---|---|
| Length of follow-up, % | |||
| Patients with 12 months or more of follow-up | 187,626 (97%) | 134,558 (97%) | < 0.001 |
| Healthcare utilization, % | |||
| Any clinic visit | 193,594 (100%) | 138,068 (100%) | 0.771 |
| Primary care visit | 191,175 (99%) | 136,898 (99%) | < 0.001 |
| Podiatry visit | 58,933 (30%) | 52,071 (38%) | < 0.001 |
| Rheumatology visit | 17,578 (9%) | 33,730 (24%) | < 0.001 |
| Nephrology (with dialysis) visit | 23,988 (12%) | 33,374 (24%) | < 0.001 |
| Symptoms, % | |||
| Gout flare | 8338 (4%) | 19,888 (14%) | < 0.001 |
| sUA labs and levels, % | |||
| sUA lab drawn during follow-up | 131,323 (68%) | 128,841 (93%) | < 0.001 |
| sUA level > 6 during follow-up | 70,847 (54%) | 119,028 (92%) | < 0.001 |
| sUA level > 8 during follow-up | 3999 (3%) | 94,698 (74%) | < 0.001 |
| Complications and outcomes, % | |||
| Amputation | 1605 (< 1%) | 1653 (1%) | < 0.001 |
| Emergency room visit | 74,383 (38%) | 75,413 (55%) | < 0.001 |
| Urgent care visit | 14,705 (8%) | 13,699 (10%) | < 0.001 |
| Hospital visit | 70,769 (37%) | 64,362 (47%) | < 0.001 |
| Death | 18,770 (10%) | 13,571 (10%) | 0.201 |
asUA serum uric acid